Epiminder (EPI) Stock Overview

Develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. More details

EPI fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Revenue has declined by 100% over the past year

Makes less than USD$1m in revenue (A$0)

EPI Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Epiminder Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Epiminder
Historical stock prices
Current Share Price	AU$1.19
52 Week High	AU$1.45
52 Week Low	AU$1.17
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-11.19%

Recent updates

Shareholder Returns

	EPI	AU Medical Equipment	AU Market
7D	n/a	-1.4%	0.01%
1Y	n/a	-6.2%	1.7%

Return vs Industry: Insufficient data to determine how EPI performed against the Australian Medical Equipment industry.

Return vs Market: Insufficient data to determine how EPI performed against the Australian Market.

Price Volatility

Is EPI's price volatile compared to industry and market?
EPI volatility
EPI Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	11.3%
Market Average Movement	9.5%
10% most volatile stocks in AU Market	18.9%
10% least volatile stocks in AU Market	3.4%

Stable Share Price: EPI's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine EPI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	Rohan Hoare	epiminder.com

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder app that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder cloud for processing; and Minder cloud, a secure, online portal which allows healthcare professionals to download patient data.

Epiminder Limited Fundamentals Summary

How do Epiminder's earnings and revenue compare to its market cap?
EPI fundamental statistics
Market cap	AU$255.67m
Earnings (TTM)	-AU$43.64m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-5.9x

P/E Ratio

Is EPI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EPI income statement (TTM)
Revenue	AU$0
Cost of Revenue	AU$0
Gross Profit	AU$0
Other Expenses	AU$43.64m
Earnings	-AU$43.64m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Feb 28, 2026

Earnings per share (EPS)	-0.20
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did EPI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/03 17:28
End of Day Share Price	2025/12/03 00:00
Earnings	2025/06/30
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Epiminder Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Epiminder LimitedCHIA:EPI Stock Report